StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT) – MarketBeat
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report released on Sunday. The firm set a “hold” rating on the stock.
Several other equities research analysts have also issued reports on the stock. JMP Securities restated a “buy” rating and set a $5.00 price target on shares of DBV Technologies in a research note on Wednesday, June 8th. HC Wainwright restated a “buy” rating and set a $10.00 price target on shares of DBV Technologies in a research note on Tuesday, May 3rd. Finally, The Goldman Sachs Group lowered shares of DBV Technologies from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $6.00 to $1.50 in a research note on Monday, May 9th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $5.50.
DBV Technologies Stock Down 0.4 %
DBV Technologies stock opened at $2.43 on Friday. DBV Technologies has a 52 week low of $1.15 and a 52 week high of $5.99. The company’s 50 day moving average price is $2.07 and its two-hundred day moving average price is $1.68. The stock has a market cap of $297.12 million, a P/E ratio of -3.12 and a beta of 1.56.
DBV Technologies (NASDAQ:DBVT – Get Rating) last posted its earnings results on Monday, May 2nd. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.47) by $0.32. The firm had revenue of $2.55 million for the quarter, compared to the consensus estimate of $2.20 million. On average, equities analysts anticipate that DBV Technologies will post -0.69 EPS for the current year.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the business. FNY Investment Advisers LLC purchased a new position in DBV Technologies in the 4th quarter valued at approximately $32,000. BlackRock Inc. grew its position in shares of DBV Technologies by 16.5% during the 1st quarter. BlackRock Inc. now owns 687,341 shares of the company’s stock valued at $1,093,000 after purchasing an additional 97,412 shares in the last quarter. Finally, Envestnet Asset Management Inc. purchased a new position in shares of DBV Technologies during the 4th quarter valued at $43,000. 19.33% of the stock is currently owned by hedge funds and other institutional investors.
About DBV Technologies
(Get Rating)
DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults.
See Also
- Get a free copy of the StockNews.com research report on DBV Technologies (DBVT)
- Three Watchlist Stocks to Capitalize on Sector Rotation
- MarketBeat: Week in Review 7/18 – 7/22
- Falling Copper Prices Weigh On Freeport McMoran’s Earnings, But Long Term Fundamentals Intact
- Snap Stock Falters As Growth Slows To Record Low
- Verizon Shares Drop On Earnings Miss, Lower Guidance
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DBV Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and DBV Technologies wasn’t on the list.
While DBV Technologies currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
In this episode, Kate chats with regular guest Rob Isbitts, who, as always, debunks some traditional investing ideas, such as “buy the dip” and only going long while the market is in rally mode.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.
Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.